D-cycloserine nasal formulation development for anxiety disorders by using polymeric gels

Drug Discoveries & Therapeutics
Yeonoh ShinGagan Kaushal

Abstract

D-cycloserine (DCS), a partial agonist at N-methyl-D-aspartate (NMDA) receptors, is used as an enhancer of exposure therapy for anxiety disorders. The purpose of the present study was to investigate the feasibility of using polymeric gels to increase the viscosity of the formulation and thereby increase the nasal residence time and sustained release of DCS in vitro. Hydroxypropyl methylcellulose (HPMC), hydroxypropyl cellulose (HPC), and methyl cellulose (MC) were prepared at concentrations of 0.5 to 5% w/v. Pluronic F-127 (PF-127) was prepared at concentrations of 15 to 35% w/v. pH, viscosity and in vitro DCS release behavior of the formulated gels were analyzed. All four gels that were tested, demonstrated sustained DCS release behavior over a 24-hour period, but with different rates. Based on the results of this study, HPMC, HPC, MC, and PF-127 are capable of increasing the viscosity of nasal gel formulations and of releasing DCS in sustained manner. Therefore, these polymeric gels can be suitable carriers for DCS nasal gel formulation.

References

May 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·B N van BerckelR S Kahn
Sep 19, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·T Kissel, U Werner
Aug 24, 1999·The Journal of Clinical Psychiatry·P E GreenbergA J Fyer
Feb 17, 2000·International Journal of Pharmaceutics·M Dahlin, E Björk
Apr 18, 2000·International Journal of Pharmaceutics·N WashingtonD A Rawlins
Jun 6, 2000·Advanced Drug Delivery Reviews·A A Hussain
Aug 24, 2000·Pharmaceutical Research·M DahlinE Brittebo
Sep 5, 2001·The American Journal of Psychiatry·D C Goff, J T Coyle
Jun 28, 2002·International Journal of Pharmaceutics·A H El-Kamel
Oct 30, 2004·The American Journal of Psychiatry·David J PoseyChristopher J McDougle
Jun 23, 2005·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·R J SalibP H Howarth
Sep 27, 2005·Advanced Drug Delivery Reviews·Michael I UgwokeRenaat Kinget
Mar 8, 2006·Archives of General Psychiatry·Stefan G HofmannMichael W Otto
Oct 10, 2006·AAPS PharmSciTech·Rita J MajithiyaRayasa S R Murthy
Jun 26, 2007·Biological Psychiatry·Matt G KushnerEdna B Foa
Sep 8, 2009·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Annette Wengst, Stephan Reichl
Apr 7, 2010·Behaviour Research and Therapy·Gregory S ChassonSabine Wilhelm
Mar 25, 2011·Journal of Pharmacy & Bioallied Sciences·Rahamatullah ShaikhRyan F Donnelly
Jan 17, 2012·Journal of Advanced Pharmaceutical Technology & Research·Mayank ChaturvediKamla Pathak
Apr 5, 2012·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·El-Sayed Ali IbrahimNoura Hassan Abdellah
Nov 28, 2013·Pharmaceuticals·Seven E TomekM Foster Olive
Apr 9, 2014·International Journal of Pharmaceutics·Shuai QianZhong Zuo

❮ Previous
Next ❯

Citations

Oct 7, 2021·Expert Review of Respiratory Medicine·De Yun WangYong Chiat Wong

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.